Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (LION Study) is evaluating the safety, tolerability, and distribution of Laquinimod Eye Drops for uveitis-related inflammation and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Laquinimod Eye Drops (laquinimod)

Snippet

Sponsor: Quan Dong Nguyen | Conditions: Inflammation, Uveitis | Phase 1 | Status: RECRUITING